Literature DB >> 9202933

Propofol: pro- or anticonvulsant?

A Borgeat1.   

Abstract

The pro- or anticonvulsant properties of propofol remain a matter of controversy. Although numerous case reports describe the appearance of abnormal movements, posturing and seizure-like activity related to the use of propofol, systematic studies in both humans and animals strongly suggest that it possesses antiepileptic properties. Propofol consistently reduces the seizure duration during electroconvulsive therapy, its use has been successful in controlling refractory status epilepticus and in animals it offers a strong protection against lignocaine- or pentylene-tetrazol-induced epilepsy. The beneficial effects of propofol may be related to its uniform depressant action on the central nervous system, to a potentialization of GABA-mediated pre- and postsynaptic inhibition, and by decreasing the release of excitatory transmitters, glutamate and aspartate.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202933     DOI: 10.1097/00003643-199705001-00004

Source DB:  PubMed          Journal:  Eur J Anaesthesiol Suppl        ISSN: 0952-1941


  3 in total

1.  Anesthetic management of a pediatric patient on a ketogenic diet.

Authors:  Junko Ichikawa; Keiko Nishiyama; Kyoko Ozaki; Misako Ikeda; Yoshitaka Takii; Makoto Ozaki
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

Review 2.  Treatment of status epilepticus in children.

Authors:  M De Negri; M G Baglietto
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 3.  [Refractory status epilepticus: diagnosis, therapy, course, and prognosis].

Authors:  F Bösebeck; G Möddel; K Anneken; M Fischera; S Evers; E B Ringelstein; C Kellinghaus
Journal:  Nervenarzt       Date:  2006-10       Impact factor: 1.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.